COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff as we address the COVID-19 situation. Learn more about COVID-19 online education, resources, and live course cancellations.
Agios - Exhibitor

www.agios.com

Contact Information:

Teresa Nissen
Teresa.Nissen@agios.com

Virtual Exhibit Hall Home

TIBSOVO (ivosidenib tablets) from Agios on Vimeo.

 

Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.

TIBSOVO Prescribing Information 

TIBSOVO Product Guide 

myAgios Patient Support Services Brochure